: Saffrox™ (Afrron® 28mg) 30 Caps – vayazoom

Free Express U.S. Shipping

Saffrox™ (Afrron® 28mg) 30 Caps
Saffrox™ (Afrron® 28mg) 30 Caps
Saffrox™ (Afrron® 28mg) 30 Caps

Saffrox™ (Afrron® 28mg) 30 Caps

Regular price
$55.90
Regular price
Sale price
$55.90
Unit price
per 
Availability
Sold out
Shipping calculated at checkout.

Saffron supports mood balance by regulating serotonergic, dopaminergic and glutamatergic Systems.

100% Natural Multifunctional antidepressant formula.

Saffrox™ main ingredient contains patented standardized "Afrron® 28mg" - Pharmaceutical quality grade saffron.

The other ingredients of the formula : Turmeric, Magnesium, Folic Acid, Vitamin B6 & B1 and Black pepper extract (Piperine).


In recent years, it has been scientifically proven in dozens of studies and publications that indicated the effectiveness of the it in the treatment of depression in experimental groups.

Initially, saffron preparations were tested against a placebo.

Later, their effect was compared to that of common antidepressants, such as Prozac.

The dose was determined, and it is found that the effectiveness of the spice increases when components of turmeric are added to the formula, which is also found to increase the effectiveness of the anti-depressant drugs.

The unique saffron extract Afrron 28mg® found in Saffrox™- is an extract produced by a pharmaceutical company, which guarantees a constant and precise amount of the active substances in Saffrox™.

Saffrox™ the only preparation contains active (reduced) form of Folic Acid

(L-Methyl Folate) that contribute to the production of Serotonin, Noradrenaline

Saffrox™ contains the most bioavailable patented Magnesium (Magnox™) for

better CNS physiological function in Hypomagnesemic patients and Dopamin supporting mood balance.

 

*30 Vegan Capsules.

*High Safety Profile - Safe for kids & adults.

*Kosher.

* Complies with the GMP standard.

* Save In A Dry Place.

*How to use: 1 capsule a day before going to bed.

 

  1. Nazila Shahmansouri et al., Journal of Affective Disorders, 2013.